Clinical Trials Browser

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT06600321 2026-03-31

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Phase 1 Recruiting

158 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07377487 2026-03-30

INDIGO

Phase NA Recruiting

51 enrolled

EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05063565 2026-03-27

ROWAN

Phase 2 Active not recruiting

100 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Phase NA Active not recruiting

120 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07191548 2025-10-10

LIVERMET-IRE

Phase NA Not yet recruiting

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT05233098 2025-03-06

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Completed

6 enrolled 15 charts

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT04926376 2024-11-29

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

Phase NA Completed

8 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Colorectal Neoplasms

NCT02301104 2024-09-05

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

Phase 1 Completed

24 enrolled

Gastrointestinal

Liver Diseases, Liver Neoplasms

NCT02112656 2024-08-20

OPTIMA

Phase 3 Completed

554 enrolled 9 charts

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT05053412 2024-08-02

HEPATIC

Completed

1,556 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT02508467 2024-04-12

A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

Phase 1 Completed

146 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Phase 1 Completed

22 enrolled 25 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms

NCT00627042 2014-10-08

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Phase 2 Completed

42 enrolled 19 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT01009593 2012-09-10

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1,035 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT00969410 2012-04-12

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

Phase 1 Completed

19 enrolled

Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes

Clinical Trials

Kirros

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

INDIGO

ROWAN

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

LIVERMET-IRE

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

OPTIMA

HEPATIC

A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases